VisionPoint Advisory Group’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,891
Closed -$1.02M 456
2025
Q4
$1.02M Sell
42,891
-6,365
-13% -$158K 0.2% 112
2025
Q3
$1.3M Sell
49,256
-3,322
-6% -$85.4K 0.26% 98
2025
Q2
$1.5M Sell
52,578
-63,533
-55% -$1.71M 0.33% 88
2025
Q1
$2.89M Buy
116,111
+5,842
+5% +$139K 0.99% 26
2024
Q4
$2.44M Sell
110,269
-36,114
-25% -$784K 0.84% 31
2024
Q3
$3.12M Buy
146,383
+17,805
+14% +$350K 1.05% 18
2024
Q2
$2.45M Buy
128,578
+13,290
+12% +$271K 0.87% 32
2024
Q1
$2.22M Buy
115,288
+76,287
+196% +$1.51M 0.8% 31
2023
Q4
$812K Buy
+39,001
New +$749K 0.3% 74

Other funds holding FMS

VisionPoint Advisory Group's FMS Position: Q1 2026 in Review

VisionPoint Advisory Group sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 42,891 shares — an estimated $1.02M sold.

VisionPoint Advisory Group first reported a position in FMS in Q4 2023 and held it in 9 quarters. The position peaked at $3.12M in Q3 2024. 218 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • VisionPoint Advisory Group reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
  • VisionPoint Advisory Group sold 42,891 Fresenius Medical Care shares in Q1 2026, an estimated $1.02M.
  • VisionPoint Advisory Group first reported a position in Fresenius Medical Care in Q4 2023 and held it in 9 quarters.
  • VisionPoint Advisory Group's Fresenius Medical Care position peaked at $3.12M in Q3 2024.
  • 218 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on VisionPoint Advisory Group's 13F filing for Q1 2026, filed 7 May 2026.